Araraquara, Brazil

Andressa Munhoz

This inventor holds 1 USPTO granted patent. Top assignee: Ems S.a.. Active years: 2009.


Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Andressa Munhoz: Innovator in Antibacterial Compounds

Introduction

Andressa Munhoz is a prominent inventor based in Araraquara, Brazil. She has made significant contributions to the field of pharmaceuticals, particularly in the development of antibacterial and antiprotozoal compounds. Her innovative work focuses on creating effective solutions for combating infections.

Latest Patents

Andressa holds a patent for "Antibacterial and/or antiprotozoal nitromidazole derivative compounds with urease inhibitor activity, process for preparing these compounds and use in pharmaceutical compositions and medicines." This patent describes nitroimidazolic derivative compounds that exhibit potent antibacterial and antiprotozoal activity, functioning as effective urease inhibitors. The application outlines the process for preparing these compounds and their potential use in various pharmaceutical compositions and medicines. She has 1 patent to her name.

Career Highlights

Andressa is currently associated with Ems S.A., a company known for its commitment to innovation in the pharmaceutical industry. Her work at Ems S.A. has allowed her to explore new avenues in drug development and contribute to advancements in medical treatments.

Collaborations

Throughout her career, Andressa has collaborated with notable colleagues, including Renato F Menegon and Lúcia Castro. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Andressa Munhoz is a trailblazer in the field of pharmaceutical innovations, particularly in the development of antibacterial compounds. Her contributions are paving the way for new treatments and improving healthcare outcomes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…